OBI licensed the Intellectual Property Right of Global Aesthetic Medicine to a designated company

Contents: 1.Date of occurrence of the event: Dec 04, 2020 2.Company name: OBI Pharma Inc. 3.Relationship to the Company (please enter “head office” or “subsidiaries”): Head office 4.Reciprocal shareholding ratios: No Applicable 5.Cause of occurrence: (1) The development of immunotherapeutic anticancer drug is the current focus of OBI. A partner with complementary resources is needed […]